IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 174 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,076,000 | -3.5% | 184,731 | +10.7% | 0.01% | +28.6% |
| Q4 2021 | $3,187,000 | -15.0% | 166,941 | +9.8% | 0.01% | -22.2% |
| Q3 2021 | $3,748,000 | -4.5% | 152,001 | +0.8% | 0.01% | -10.0% |
| Q2 2021 | $3,925,000 | +84.6% | 150,839 | +124.6% | 0.01% | +66.7% |
| Q1 2021 | $2,126,000 | -70.5% | 67,145 | -56.7% | 0.01% | -70.0% |
| Q4 2020 | $7,196,000 | +2.9% | 155,090 | -27.0% | 0.02% | -20.0% |
| Q3 2020 | $6,993,000 | +61.4% | 212,417 | +34.6% | 0.02% | +47.1% |
| Q2 2020 | $4,332,000 | -25.5% | 157,822 | -18.7% | 0.02% | -46.9% |
| Q1 2020 | $5,811,000 | +58.0% | 194,138 | +46.1% | 0.03% | +60.0% |
| Q4 2019 | $3,679,000 | +850.6% | 132,894 | +524.4% | 0.02% | +900.0% |
| Q3 2019 | $387,000 | – | 21,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |